ON AIR NOW

LISTEN NOW

Weather

heavy-rain-night
85°
Partly Cloudy
H 93° L 75°
  • heavy-rain-night
    85°
    Current Conditions
    Partly Cloudy. H 93° L 75°
  • cloudy-day
    76°
    Morning
    Partly Cloudy. H 93° L 75°
  • partly-cloudy-tstorms-day
    88°
    Afternoon
    Sct Thunderstorms. H 89° L 75°
LISTEN
PAUSE
ERROR

The latest newscast

00:00 | 00:00

LISTEN
PAUSE
ERROR

The latest traffic report

00:00 | 00:00

LISTEN
PAUSE
ERROR

The latest forecast

00:00 | 00:00

National Govt & Politics
Setbacks for Trump's drive to lower prescription drug costs
Close

Setbacks for Trump's drive to lower prescription drug costs

Setbacks for Trump's drive to lower prescription drug costs
Photo Credit: AP Photo/Alex Brandon
President Donald Trump speaks about kidney health at the Ronald Reagan Building and International Trade Center, accompanied by Health and Human Services Secretary Alex Azar, left, Wednesday, July 10, 2019, in Washington. (AP Photo/Alex Brandon)

Setbacks for Trump's drive to lower prescription drug costs

After two setbacks this week, President Donald Trump is now focusing his drive to curb drug costs on congressional efforts aimed at helping people on Medicare and younger generations covered by workplace plans.

The White House on Thursday yanked its own regulation to ease the financial bite of costly medications for those on Medicare by letting them receive rebates that drugmakers now pay to insurers and middlemen. A congressional agency's estimate that the plan would have cost taxpayers $177 billion over 10 years seemed to seal its fate.

Earlier a federal judge ruled that the administration lacked the legal authority to require drugmakers to disclose list prices in their TV ads. The ruling Monday blocked a highly visible change expected to have started this week.

Both price disclosure and the rebate idea were part of a strategy on drug costs that Trump announced at the White House with much fanfare last year.

"This is a big setback," said Peter Bach, director of the Center for Health Policy and Outcomes at New York's Memorial Sloan Kettering Cancer Center. The rebate rule "was not good policy (since) it would have increased spending on prescription drugs even if it mildly reduced out-of-pocket costs in some cases. But nevertheless this was a cornerstone of the blueprint."

White House spokesman Judd Deere said the rebate proposal was withdrawn "based on careful analysis and thorough consideration."

Deere said Trump is not backing away from his promise to lower drug prices, and the administration is setting its sights on bipartisan legislation . One idea would cap drug copays for people with Medicare, which would produce savings for seniors taking costly drugs. That's another way to achieve a similar goal as the rebate plan.

"The Trump administration is encouraged by continuing bipartisan conversations about legislation to reduce outrageous drug costs imposed on the American people, and President Trump will consider using any and all tools to ensure that prescription drug costs will continue to decline," Deere said in a statement.

While agreeing it's a setback for Trump, John Rother of the National Coalition on Health Care said that if legislation could be worked out, "that might actually lead to a better outcome." His organization is an umbrella group that represents a cross section of business and consumer groups.

The chairman of the Senate Finance Committee, Charles Grassley of Iowa, and the committee's top Democrat, Sen. Ron Wyden of Oregon, are trying for a compromise centered on lowering drug costs for government programs such as Medicare and Medicaid. Top administration officials this week participated in a closed-door meeting between Grassley and Republican senators on his committee.

Grassley said in a statement that he had concerns about the administration's rebate rule, but was confident about the prospects for legislation. "While the final details are still being negotiated, we're on track to report a bill out of committee very soon," he said.

Separately, Grassley and Illinois Sen. Dick Durbin, the chamber's second-ranking Democrat, are pushing legislation that would grant the government the power to require drug companies to disclose their prices in consumer advertising.

House committees are also working on legislation and Speaker Nancy Pelosi, D-Calif., remains in contact with the White House on a drug cost compromise. Changes to Medicare often have an impact on employer insurance, but the main dividend for working families could come from legislation to promote pharmaceutical competition.

The rebate plan was crafted by Health and Human Services Secretary Alex Azar but ran into opposition from White House budget officials. That pushback stiffened after the nonpartisan Congressional Budget Office estimated that the plan would have little effect on manufacturer prices and would cost Medicare $177 billion over 10 years by leading to higher premiums subsidized by taxpayers.

Trump's reversal on rebates was a win for insurers and middlemen called "pharmacy benefit managers" who administer prescription drug plans for large blocks of insured patients.

It was a defeat for the pharmaceutical industry, which had lobbied to promote rebates. Drugmakers prefer that to other approaches lawmakers are considering. Those include "inflation rebates" that drugmakers would pay directly to Medicare if they raise prices beyond a yet-to-be-determined measure.

"The administration has abandoned one of the only policy solutions that would have truly lowered what patients are forced to pay out of pocket for the medicines they need," Jim Greenwood, head of the Biotechnology Innovation Organization, said in a statement.

Shares of pharmaceutical companies dropped Thursday but drug store chains and insurers gained. Drugmaker Merck & Co. dropped 4.5% while UnitedHealth climbed 5.5% and CVS Health gained 4.7%.

Rebates are a largely unseen part of the complex world of drug pricing.

Under the administration's plan, drugmaker rebates now paid to insurance companies and their middlemen would have gone directly to seniors in Medicare's Part D program when they filled their prescriptions.

But congressional analysts concluded that drug companies were unlikely to lower list prices across the board in response to the plan. Meanwhile, insurers would raise premiums to compensate for the loss of rebates.

Labor Department data indicate that changes may be afoot with drug prices.

Overall prescription drug inflation seems to have stabilized, with more monthly declines than increases recently. The White House credits Trump for that change, but independent experts say the trend isn't totally clear yet.

The administration's rebate reversal was first reported by Axios.

___

AP Health Writer Tom Murphy in Indianapolis contributed to this report.

Read More

The Latest Headlines You Need To Know

  • President Trump continues his public criticism of House democrats Ayanna Pressley, Rashida Tlaib, Alexandria Ocasio-Cortez and Ilhan Omar. He tweets, “The “Squad” is a very Racist group of troublemakers who are young, inexperienced, and not very smart. They are pulling the once great Democrat Party far left, and were against humanitarian aid at the Border...And are now against ICE and Homeland Security. So bad for our Country!” These comments come after President Trump last week said those four freshman House Democrats should 'go back to the crime infested places' from which they came. This also comes after a crowd at a Trump campaign rally in North Carolina chanted 'send her back.
  • A California woman and her boyfriend have been charged in connection with their newborn son’s death after investigators learned they strangled the boy at the hospital shortly after he was born, authorities said. Andrea Torralba, 20, and David Villa, 21, both of Oxnard, are being held in the Ventura County Jail on suspicion of felony assault on a child causing death, Oxnard Police Department officials said. Jail records show Villa, who is described as a field worker, is being held in lieu of $5 million. ABC 7 in Los Angeles reported that Torralba’s bail was set at $1 million. >> Read more trending news  Oxnard police investigators said officers were called just before 8 a.m. Friday to St. John’s Medical Center, where they learned a newborn boy was in critical condition with serious injuries. The boy was found unresponsive and despite all medical efforts, he died of his injuries. Detectives from the department’s Family Protection Unit learned that Torralba and Villa strangled the newborn until he lost consciousness, police officials said. Oxnard police Sgt. Brandon Ordelheide told ABC 7 that the couple, when questioned by detectives, admitted they did not want the baby. Both were arrested and charged in the boy’s death.
  • Police have apprehended an Ohio man accused of stabbing and setting fire to two women in a Willoughby Hills home before leaving with three young children, authorities said. >> Read more trending news  According to WEWS-TV, 27-year-old Allen Crawford bound, stabbed and burned the women – one of whom is the mother of his children – Saturday afternoon at the Willoughby Hills Towers, police said. He then fled the scene with the children, who are 2, 4 and 5 years old, authorities said. Shortly after 5 p.m., one woman broke free and called police, the TV station reported. Both women, who suffered critical injuries, were flown to a nearby hospital, authorities said. Crawford took the children to his mother's Cleveland home before turning himself in around 9 p.m., police told WEWS. All three were safe.  Information about what charges Crawford may face was not immediately available. Read more here.
  • A tropical wave churning off shore has a low chance of developing further into a tropical system this upcoming week. This system could potentially bring a surge in moisture to Florida.  Considering its position, movement and forward speed, this tropical wave is expected to be near or at our latitude by Tuesday.  As for Monday's forecast, WFTV Channel 9 meteorologist Brian Shields said there's 50 percent chance of scattered rain and storms, mainly in the afternoon. The high temperature will still be toasty, clocking in at 93. By Tuesday, the few models currently available forecast the tropical system to be parallel to Central Florida. How close to Central Florida will it be? That will all depend on the high pressure system over the Atlantic Ocean.  Currently, we are monitoring this wave closely. The wave seems to be moving fast toward Florida, not giving it time to further develop as it gets close to Florida. We can expect high rain chances to start the week, especially Tuesday.  Temperatures will remain seasonably hot, with highs in the low 90s and lows in the mid-70s.
  • Bud Light is getting on the fun surrounding the 'Area 51 raid' that's been in the news recently. First, the brand distanced itself, tweeting, 'We'd like to be the first brand to formally announce that we will not be sponsoring the Area 51 raid' early last week. But on Thursday (July 17th) Bud Light changed its tune, tweeting, 'Screw it. Free Bud Light to any alien that makes it out.' They followed that by announcing a special edition beer, the Area 51 Special Edition. The top of the can reads, 'Greetings Earthlings. This is the famous Area 51. We know of no space beer by any other life form which is brewed and aged to be more refreshing. Our cryogenic aging produces a light-bodied space lager with a fresh tastes, a crisp, clean finish, and a smooth drinkability. Take us to your leader...for drinks.

Washington Insider

  • In a dramatic expansion of a process known as 'expedited removal' of illegal immigrants in the United States, the Trump Administration will start applying that everywhere in the United States - to anyone who has been in the U.S. illegally for less than two years - as critics quickly said they would challenge the change in federal court. 'The effect of that change will be to enhance national security and public safety,' the Department of Homeland Security states in a new rule set to go into effect on Tuesday, which the notice says will allow 'DHS to address more effectively and efficiently the large volume of aliens who are present in the United States unlawfully.' Up until this change, expedited removal was only used for illegal immigrants who were detained within 100 miles of the border - now it can be enforced anywhere in the U.S. Under the Immigration and Nationality Act, the Trump Administration argues the Acting Homeland Security Secretary has the 'sole and unreviewable discretion' to change 'the scope of the expedited removal designation,' shifting it from the 100 mile policy to one that applies nationwide. Critics denounced the immigration policy change, with some vowing to challenge the move in court. 'One of the major problems with expedited removal is that the immigration officer making the decision virtually has unchecked authority,' said the American Immigration Council, as the process does not involve an immigration judge or any type of court hearing. 'We will sue to end this policy quickly,' said Omar Jadwat of the American Civil Liberties Union, who charged that deportations could occur with 'less due process than people get in traffic court.' 'This is a massive and dangerous change,' said Aaron Reichlin-Melnick of the American Immigration Council, which is joining in the ACLU legal challenge to the new policy. The announcement marked the second straight week that the Trump Administration had rolled out a new immigration policy - last Monday, the feds announced a new plan to restrict asylum claims by migrants from Central America. Those plans are also facing a legal challenge from the ACLU and other groups.